key: cord-0020368-zreogye4
authors: Khan, Nabab; Geiger, Jonathan D.
title: Role of Viral Protein U (Vpu) in HIV-1 Infection and Pathogenesis
date: 2021-07-27
journal: Viruses
DOI: 10.3390/v13081466
sha: 7df5bef190110cf5b0efb473841ecb18c2a44244
doc_id: 20368
cord_uid: zreogye4

Human immunodeficiency virus (HIV)-1 and HIV-2 originated from cross-species transmission of simian immunodeficiency viruses (SIVs). Most of these transfers resulted in limited spread of these viruses to humans. However, one transmission event involving SIVcpz from chimpanzees gave rise to group M HIV-1, with M being the principal strain of HIV-1 responsible for the AIDS pandemic. Vpu is an HIV-1 accessory protein generated from Env/Vpu encoded bicistronic mRNA and localized in cytosolic and membrane regions of cells capable of being infected by HIV-1 and that regulate HIV-1 infection and transmission by downregulating BST-2, CD4 proteins levels, and immune evasion. This review will focus of critical aspects of Vpu including its zoonosis, the adaptive hurdles to cross-species transmission, and future perspectives and broad implications of Vpu in HIV-1 infection and dissemination.

Human immunodeficiency virus (HIV) is a lentivirus that belongs to the Retroviridae family. The HIV retrovirus contains two RNA molecules with three prototypic genes that encode group-specific antigen (gag), envelope (env), and polymerase (pol) proteins [1] [2] [3] . HIV isolates have been classified into two types: HIV-type 1 (HIV-1) and HIV-type 2 (HIV-2). HIV-1 is the causative agent of HIV/AIDS, while HIV-2 is constrained to some welldefined Central and Western Africa regions; relative to HIV-1, HIV-2 has weak transmission capabilities [4, 5] . Based on phylogenetic analysis, HIV-1 shows substantial similarities to the virus SIVgor that infects gorillas (Gorilla gorilla) and the virus SIVcpz that infects chimpanzees (Pan troglodytes troglodytes). HIV-2 resembles the virus SIVsmm that infects sooty mangabey monkeys (Cercocebus atys). HIV-1 evolved from chimpanzees and/or gorillas by independent cross-species transmissions of SIVs [4, 5] .

The HIV-1 virus has been subdivided into M, N, O, and P subtypes according to their origin and distribution patterns within the human population. HIV-1 M is globally distributed and is a major factor causing the pandemic disease AIDS. HIV-1 N is rare (non-major/non-outlier) and originated from chimpanzees [5] . HIV-1 O and P groups have close relationships to the virus SIVgor isolated from gorillas; geographically, the O group virus is constrained to Cameroon and surrounding countries [5] . The P group virus was discovered to come from two individuals in Cameroon. Vpu protein is encoded by all groups of HIV-1, but biological differences have been noted between the various sources of Vpu proteins. Pandemic M group viruses contain Vpu proteins that are more highly active than do other groups [5] . Clearly, one needs to understand the functions of Vpu proteins to understand their roles in controlling HIV-1 infection and HIV/AIDS disease pathogenesis.

Vpu was initially characterized as an U open reading frame (ORF) product localized in the HIV-1 genome between the env and tat exons [6] . The Vpu protein is translated from bicistronic mRNA of env-vpu presumably through leaky scanning of ribosomes from the initiation codon of the vpu gene [7, 8] . The vpu gene is encoded in the HIV-1 genome, but it is not present in the genomes of HIV-2 and of SIVs such as SIV from rhesus macaques (SIVmac) and SIV from sooty mangabey (SIVsmm) [4, 5, 9] . However, structural homologs of Vpu have been identified in SIV from chimpanzee (SIVcpz), as well as in SIV from the greater spot-nosed monkey (Cercopithecus nictitans; SIVgsn), the mona monkey (Cercopithecus mona; SIVmon), the mustached monkey (Cervicopithecus Cephus; SIVmus), Dent's mona monkey (Cercopithecus mona denti; SIVdent), and recently in gorilla (Gorilla gorilla; SIVgor) [9] [10] [11] [12] [13] .

Vpu is a multimeric integral membrane phosphoprotein with 81 amino acids [14, 15] . It has three distinct alpha-helices: the N-terminus proximal transmembrane domain (Helix1-TMD: 6-29 residues) and two C-terminus domains, Helix 2 (32-52 residues) and Helix 3 (57-72 residues) [16-19] ( Figure 1 ). Helix-2 is amphipathic and is hydrophobic with polar residues on the sides. The hydrophobic portion is buried in plasma membranes, while the hydrophilic region is cytoplasmic [20]. Helix-3 contains acidic amino acids interconnected by two phosphorylated Serine residues: S52 and S56 [21] . Protein kinase casein kinase 2 (CK-2) catalyzes the phosphorylation of the serines ( Figure 1 ) and these posttranslational modifications regulate associations between Helix 3 and beta-TrCP/ubiquitin ligase complexes [22, 23] . Vpu once oligomerized can form pentameric pore-like structures through which selective monovalent cations can pass [24-26]. Vpu protein is composed of three different distinct alpha helices: the N-terminus proximal transmembrane domain (Helix1-TMD: 6-29 residues) and a cytoplasmic domain that consists of two alpha helices (Helix 2: 32-52 residues, Helix 3: 57-72 residues). The first cytoplasmic helix shows amphipathic behavior with hydrophobic and polar residues on the sides. The hydrophobic portion is buried in the cell membrane, while the hydrophilic region is exposed to the cytoplasmic side. The second cytoplasmic helix is formed by acidic amino acids. Two phosphorylated serine residues, S52 and S56, interconnect these cytoplasmic helices.

Vpu proteins localize to the plasma membranes, endoplasmic reticulum (ER), and trans-Golgi network (TGN) [27] [28] [29] [30] . Sequence analysis of the cytosolic domain of Vpu shows the presence of putative trafficking signals that carry variations in amino acid residues among different subtypes of Vpu. These signals include YXXΦ, a conserved tyrosine-based sorting motif (where Φ represents a hydrophobic residue), and a ([D/E] XXXL [/I/V]) sorting motif consisting of acidic residue/dileucine-based sequences that are present in the hinge portion between the cytosolic domain and the TMD. The latter is involved in endocytosis and the targeting of transmembrane host proteins to lysosomes [31] . Another ([D/E] XXXL [/I/V]) motif is present in the second alpha-helix of the cytoplasmic domain [29] . Several primary isolates of HIV-1 and laboratory-adapted viruses carry polymorphisms of the vpu gene that are based on variations of putative trafficking signal sequences [32] and these polymorphisms regulate subcellular distribution patterns and biological activities of the Vpu protein.

Vpu has two well-established functions in HIV-1 infection. First, through the ubiquitinproteasomal pathway, it enhances the degradation of CD4 protein produced de novo in the endoplasmic reticulum [ Table 1 ). Constitutive expression of CD4 can be harmful to productive viral replication and dissemination [48] . De novo produced CD4 molecules bind Env polyproteins with high affinity within the endoplasmic reticulum, prevent the transport and processing of Env precursor to its products gp41 and gp120 [49, 50] , and reduce secretion of infectious progeny virion particles from infected cells. Vpu can enhance degradation of de novo produced CD4 by retention of CD4 in the endoplasmic reticulum through interactions between Vpu and CD4 via their transmembrane domains, poly-ubiquitination of CD4, and transport to the ERAD (ER-associated degradation) pathway [33,57,58]. The integrity of the cytoplasmic domain of Vpu protein and the DSGXXS motif containing the S52/S56 phosphoserine residues are critical to proteasomal degradation of CD4; Vpu interacts directly with β-TrCP1, β-TrCP2 (β-transducin repeat-containing protein 1 or 2), two adaptor molecules (SKP1-cullin-F-Box), and the E3 ubiquitin ligase complex [59, 60] . The interaction of SCF-β-TrCP with Vpu induces the poly-ubiquitination of CD4 through binding to lysine, serine, and threonine residues [58] ( Figure 2 ). Without those residues, SCF-mediated interactions between Vpu with CD4 result in retention of the receptor in the ER. Without the ERAD complex (VCP-UFDIL-NPL4), Vpu fails to pull CD4 out of the endoplasmic reticulum and reduces proteasomal degradation [58] ( Figure 2 ). Decreased interactions between β-TrCP/Vpu reduce proteasomal degradation by the ERAD pathway of several cellular factors including β-catenin, ATF4, and p53 [40]. BST-2 can inhibit the release of almost all enveloped viruses, including retroviruses, flaviviruses, herpesviruses, arenaviruses, rhabdoviruses, and paramyxoviruses [65, 66] . Therefore, BST-2 has been proven to be a critical innate immune factor for restricting viral release. Primate lentiviruses express three different proteins that counteract BST-2 antiviral activity: Vpu for HIV-1 [28,36]; Nef for SIV major isolates [51, 67, 68] ; and Env for HIV-2, SIVagmTan, and SIVmac239∆nef isolates [69] [70] [71] [72] . HIV-1 Vpu, HIV-2 Env, and SIV Nef all decrease cell surface levels of BST-2 from budding viral sites to favor virus release [69] [70] [71] [72] .

BST-2 is a 30-36 kDa type II integral membrane protein that is expressed constitutively as well as following induction by type-I interferon or other pro-inflammatory signals [65] . It consists of a short N-terminal cytoplasmic tail inter-linked to a transmembrane domain and an extracellular domain anchored in the membrane via its glycosylphosphatidylinositol (GPI) moiety in the C-terminal region [73] . BST-2 is distributed mainly in cholesterol-rich microdomains of the cell membrane and intracellular compartments such as the trans-Golgi-network (TGN) and endosomes [73, 74] .

BST-2 can physically tether de novo generated virion particles at the cell membrane of infected cells, thereby decreasing virus release [75, 76] . This tethering occurs following formation of homodimers via parallel disulfide-bonding and cross-linking with virions particles and plasma membranes through its membrane anchoring N-terminal domains [75, 77] . BST-2 makes "axial" arrangements in which the BST-2 GPI anchors remain connected to the membrane of infected cells. Vpu downregulates BST-2 and interactions between Vpu and BST-2 utilize their respective transmembrane domains. The Ala14, Ala18, and Trp22 residues of the Vpu TMD are crucial for BST-2 downregulation from the cell membrane through direct interaction with specific residues on BST-2 (Val, Iso, Leu, and Leu) [78, 79] . These residues are involved in TMD-TMD interactions, create an anti-parallel helix-helix interface [80] , and maintain the interaction between these proteins [81, 82] . The antagonistic effect of Vpu on BST-2 activity takes place by three sequential steps: downregulation from the cell surface, restriction of BST-2 recycling, and decline in intracellular BST-2 levels. Downregulation of BST-2 at the cell surface is mediated by clathrin-coated vesicles through direct interaction of the AP2 (clathrin adaptor complex) with a Y6XY8 motif (non-canonical dual Tyrosine residues) present in the cytoplasmic tail of BST-2 [74, 83] . Vpu restricts the recycling of internalized BST-2 to the cell membrane and blocks the translocation of de novo generated BST-2 to the cell membrane [84] [85] [86] [87] .

BST-2 is degraded by ubiquitination following recruitment of the SCF-β-TrCP-E3 ligase complex to the DS52GxxS56 motif that is present in the cytosolic region of Vpu [88, 89] ( Figure 3 ). Vpu enhances ubiquitination of BST-2 through lysine/serine and threonine amino acid residues present in the cytoplasmic tail of Vpu [89] . Vpu induces ubiquitination and degradation of both BST-2 and CD4 by identical molecular mechanisms, although the outcomes are different. Instead of targeting BST-2 to proteasomes, Vpu induces the β-TrCP-dependent sorting of BST-2 to lysosomes [77, 84, 88] . Moreover, it has been shown that the ESCRT complex and Rab7 are critical components of the endo-lysosomal trafficking involved in the degradation of BST-2 [90, 91] (Figure 3 ).

Of the four HIV-1 groups, the M group is the most highly pathogenic and transmissible because Vpu is highly active, and this increases the ability of the virus to disseminate from one cell to another by counteracting the host protein BST-2 and evading the immune system (Table 1) . 

Innate immune responses play a significant role in host defenses against viral infections. Innate immune cells like natural killer (NK) and dendritic cells respond to invading viruses and contribute to controlling viral infection and replication during the initial stages of infection [92] [93] [94] . However, Vpu stabilizes HIV-1 infection and replication by evading immune responses by CD1d and NTB-A downmodulation [42, 54] . Vpu also downregulates MHCII molecules from the cell surface to inhibit antigen presentation [39] . Together, these responses help HIV-1-infected cells escape cytotoxic and natural killer cells' ability to kill the infected cell.

Vpu protein can be cytotoxic. It induces cell stress through induction of Fas ligand, p53 stabilization, and activating JNK signaling pathways [40, [95] [96] [97] . Oxidative stress may also contribute to cell death because Vpu induces oxidative stress by stabilization of p53 protein, increasing TGF-β protein levels and increasing the release of cytotoxic substances from HIV-1-infected cells [40, [98] [99] [100] . NADPH oxidase plays fundamental roles in the generation of reactive oxygen species (ROS) and can induce cell death [101] [102] [103] . P67phox, a subunit of NADPH oxidase enzyme, has TPR repeat sequences including the Vpu-interacting partner SGTA [104, 105] .

Vpu can oligomerize its transmembrane domain and form pentamer ion channel pores selective for monovalent cations [16, 24, 26] . Vpu ion channel activity is regulated by serine (S23) amino acids that are conserved in HIV-1 M group viruses [106, 107] . TASK-1, a mammalian two-pore potassium channel protein with structural homology protein to Vpu, stabilizes cell membrane potential [108, 109] . Vpu interacts with TASK-1 proteins, inhibits its ion channel activity, and depolarizes plasma membranes to enhance cellular secretions [108] [109] [110] .

HIV-1 gene activation is dependent on host transcription factors including NF-κB, NFAT, and Ap-1 [111] . Vpu and its structural homolog TASK-1 inhibit transcription of unintegrated HIV-1 DNA in an NF-κB-dependent manner [112] . Vpu mutants (replaced transmembrane domain of Vpu with its structural homologs) also suppress virus production by reducing LTR activity by an unknown mechanism [112, 113] . Thus, Vpu appears to be capable of regulating LTR activity to control virus production in infected cells possibly through the involvement of zinc finger proteins and histone deacetylase (HDAC) [114] [115] [116] .

Vpu protein is localized to plasma membranes, ER, TGN complex, and endosomes [27, 29] . Endosomes fuse with lysosomes and generate endolysosomes, which play crucial roles in physiological and pathological conditions such as antigen presentation, membrane trafficking, metabolism, autophagy, viral infections, cancer, neurological complications, and metabolic disorders [31, [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] . Endolysosomes are highly acidic organelles and this acidity is regulated by the proton pump v-ATPase [127] [128] [129] , BK channels [130] , TRPML1 channels [130] , and two-pore channels [131] . Vpu interacting protein ATP6V0C is a subunit of the v-ATPase pump and promotes intracellular aggregation of BST-2 and contributes to HIV-1 release [132] . However, much is still unclear about the effects of Vpu on v-ATPase, endolysosome acidification, endolysosomes' regulatory functions, membrane trafficking, and autophagy.

Autophagy can enhance virus release and secretions from infected macrophage or monocyte cells [133] [134] [135] . HIV-1 enhances autophagy, while HIV-1 Nef blocks autophagy by direct interactions with Beclin and TFEB sequestration [136, 137] . However, very little is currently known about the effects of Vpu on endolysosome degradation or autophagy pathways.

Vpu is an HIV-1 protein that counteracts host factors crucial for disseminating virus and disease progression. The primary targets of Vpu are cell surface host proteins that promote ubiquitination and proteasomal degradation processes [138] [139] [140] . Vpu might be targeted therapeutically to block the formation of heterooligomeric interactions between Vpu and host proteins at the cell surface as well as to suppress the progression of HIV-1 infection [141] . Moreover, Vpu disturbs the ubiquitination of host proteins by interacting with cellular factor β-TrCP through the cytosolic DSGxxS motif [138] .

Author Contributions: All authors contributed equally. All authors have read and agreed to the published version of the manuscript.

We gratefully acknowledge different research funding support provided by the National Institute of Health (NIH), USA; P30GM100329, U54GM115458, R01MH100972, R01MH105329, R01MH119000, 2R01NS065957, and 2R01DA032444. We would like to thank Parinaz Ghanbari for designing the illustrations contained in this article. [CrossRef] 

HIV-1: Fifteen proteins and an RNA

The structural biology of HIV-1: Mechanistic and therapeutic insights

HIV virology and pathogenetic mechanisms of infection: A brief overview

The evolution of HIV-1 and the origin of AIDS

Origins of HIV and the AIDS pandemic. Cold Spring Harb

A novel gene of HIV-1, vpu, and its 16-kilodalton product

Both linear and discontinuous ribosome scanning are used for translation initiation from bicistronic human immunodeficiency virus type 1 env mRNAs

Mechanism of translation of monocistronic and multicistronic human immunodeficiency virus type 1 mRNAs

Species-specific host factors rather than virus-intrinsic virulence determine primate lentiviral pathogenicity

Characterization of a novel vpu-harboring simian immunodeficiency virus from a Dent's Mona monkey (Cercopithecus mona denti)

Identification of a new simian immunodeficiency virus lineage with a vpu gene present among different cercopithecus monkeys (C. mona, C. cephus, and C. nictitans) from Cameroon

Cell type-dependence for Vpu function

The antiviral activities of tetherin

Antiviral inhibition of enveloped virus release by tetherin/BST-2: Action and counteraction

Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2

Nef proteins from simian immunodeficiency viruses are tetherin antagonists

Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV

Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment

Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin

Tetherin inhibits HIV-1 release by directly tethering virions to cells

Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane

HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes

Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility

Determinants of Tetherin Antagonism in the Transmembrane Domain of the Human Immunodeficiency Virus Type 1 Vpu Protein

HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions

Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals

Vpu binds directly to tetherin and displaces it from nascent virions

Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif

Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking

HIV-1 Vpu Blocks Recycling and Biosynthetic Transport of the Intrinsic Immunity Factor CD317/Tetherin To Overcome the Virion Release Restriction

Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens

HIV-1 Vpu antagonizes BST-2 by interfering mainly with the trafficking of newly synthesized BST-2 to the cell surface

Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism

Serine-threonine ubiquitination mediates downregulation of BST-2/tetherin and relief of restricted virion release by HIV-1 Vpu

Berlioz-Torrent, C. The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation

Berlioz-Torrent, C. Rab7A is required for efficient production of infectious HIV-1

The unique role of natural killer T cells in the response to microorganisms

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections

Innate immunity against HIV-1 infection

Vpu Increases Susceptibility of Human Immunodeficiency Virus Type 1-Infected Cells to Fas Killing

The human immunodeficiency virus type 1 accessory protein Vpu induces apoptosis by suppressing the nuclear factor kappaB-dependent expression of antiapoptotic factors

The HIV-1 Vpu protein induces apoptosis in Drosophila via activation of JNK signaling

The expression of HIV-1 Vpu in monocytes causes increased secretion of TGF-β that activates profibrogenic genes in hepatic stellate cells

PML is a ROS sensor activating p53 upon oxidative stress

Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders

Role of NADPH oxidase in the apoptotic death of cultured cerebellar granule neurons. Free Radic

Structural and Functional Characterization of Human SGT and Its Interaction with Vpu of the Human Immunodeficiency Virus Type 1

Structure of the TPR domain of p67phox in complex with Rac

Molecular dynamics simulations reveal the HIV-1 Vpu transmembrane protein to form stable pentamers

Biophysical characterization of Vpu from HIV-1 suggests a channel-pore dualism

Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel

Vpu: Putting a Channel to the TASK

Membrane Potential Depolarization as a Triggering Mechanism for Vpu-Mediated HIV-1 Release

Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage

Human immunodeficiency virus type 1 Vpu and cellular TASK proteins suppress transcription of unintegrated HIV-1 DNA

The HIV-1 Vpu transmembrane domain topology and formation of a hydrophobic interface with BST-2 are critical for Vpu-mediated BST-2 downregulation

A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression

Repression of the HIV-1 5' LTR promoter and inhibition of HIV-1 replication by using engineered zinc-finger transcription factors

ZBRK1 represses HIV-1 LTR-mediated transcription

Endolysosomes Are the Principal Intracellular Sites of Acid Hydrolase Activity

Endocytic Delivery to Lysosomes Mediated by Concurrent Fusion and Kissing Events in Living Cells

Endolysosome mechanisms associated with Alzheimer's disease-like pathology in rabbits ingesting cholesterol-enriched diet

Endosome maturation

The Lysosome as a Regulatory Hub

Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments

Involvement of organelles and inter-organellar signaling in the pathogenesis of HIV-1 associated neurocognitive disorder and Alzheimer's disease

Possible Therapeutic Use of Natural Compounds Against COVID-19

Age-related endolysosome dysfunction in the rat urothelium

Antigen Processing for MHC Class II Presentation via

Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease

Lysosomal acidification mechanisms

Regulation of V-ATPase Assembly in Nutrient Sensing and Function of V-ATPases in Breast Cancer Metastasis

BK channels regulate extracellular Tat-mediated HIV-1 LTR transactivation

Two-pore channels regulate Tat endolysosome escape and Tat-mediated HIV-1 LTR transactivation

The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release

Dual role of autophagy in HIV-1 replication and pathogenesis

Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages

Macroautophagy Regulation during HIV-1 Infection of CD4+ T Cells and Macrophages. Front

Human Immunodeficiency Virus Type 1 Nef Inhibits Autophagy through Transcription Factor EB Sequestration

HIV-1 Nef counteracts autophagy restriction by enhancing the association between BECN1 and its inhibitor BCL2 in a PRKN-dependent manner

Modulation of HIV-1-host interaction: Role of the Vpu accessory protein

HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4 + T Cells

HIV-1 Vpu mediated downregulation of CD155 requires alanine residues 10, 14 and 18 of the transmembrane domain

Vpu matchmakers as a therapeutic strategy for HIV infection